Max India (NSE:MAXIND) Beta: 1.5339 (As of Jun. 26, 2026)


NSE:MAXIND Max India Ltd NSE:MAXIND
66 GF Score
Price ₹159.04
GF Value ₹205.35
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Max India Beta?

Max India NSE:MAXIND -3.94% 66 Beta is 1.5339 as of Jun. 26, 2026. GuruFocus rates NSE:MAXIND with a GF Score™ of 66/100 and a GF Value™ of ₹205.35 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Max India's Beta is 1.5339.


Max India  (NSE:MAXIND) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Max India Beta Related Terms


Max India Beta Historical Data

* Premium members only.

The historical data trend for Max India's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Max India Beta Chart

Max India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.81 1.30 1.46

Max India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 1.36 1.24 1.31 1.46

NSE:MAXIND vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Max India's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Max India Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Max India's Beta distribution charts can be found below:

* The bar in red indicates where Max India's Beta falls into.


NSE:MAXIND
66GF Score
Max India Ltd NSE:MAXIND
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Max India Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5339 mean?
Max India (NSE:MAXIND) has a Beta of 1.5339 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Max India and its competitors.
Is Max India's Beta too high?
Max India's current Beta is 1.5339. Overall, Max India has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max India's Beta compare to HCA and THC?
Max India's Beta of 1.5339 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Max India and its competitors. Max India's current Beta is 1.5339. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max India stock overvalued right now?
Based on GuruFocus' analysis, Max India (NSE:MAXIND) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹205.35, compared to a current price of ₹159.04 — trading 22.6% below its estimated fair value. The current Beta is 1.5339. Max India's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Max India (NSE:MAXIND), the current Beta is 1.5339 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Max India (NSE:MAXIND) Overvalued in 2026?

Based on GuruFocus' analysis, Max India stock appears to be undervalued. The current stock price of ₹159.04 is trading 22.6% below its estimated GF Value™ of ₹205.35. GuruFocus considers Max India to be Modestly Undervalued.

Key valuation signals for NSE:MAXIND:

  • Beta: 1.5339
  • GF Value™: ₹205.35 vs. price of ₹159.04 (22.6% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the NSE:MAXIND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Max India Business Description

Other Exchanges 543223:India
Address Landmark House, Plot No- 65, 3rd Floor, Sector- 44, Gurugram, HR, IND, 122003
Max India Ltd is a multi-business corporate that operates in the healthcare sector. The company provides healthcare services. Also, the company provides health insurance policies, senior-living communities, and other health-related training services. The business operates in four segments namely, Business Investments, Senior Living, Assisted Care, and Other. It derives maximum revenue from Senior Living segment.
66GF Score

Get the complete analysis for NSE:MAXIND

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹159.04
Price
₹205.35
GF Value